Centrally-administered opioid selective agonists inhibit drinking in the rat.

作者: Robert L. Spencer , David Deupree , Sigmund Hsiao , Henry I. Mosberg , Victor Hruby

DOI: 10.1016/0091-3057(86)90233-9

关键词: OpioidPharmacologyAgonistMorphineChemistryκ-opioid receptorEthylketocyclazocineDynorphinPotencyEndocrinologyInternal medicineEnkephalin

摘要: The effects of intracerebroventricular injection mu (morphine), kappa (dynorphin-(1–13), ethylketocyclazocine, and U50,488H), delta ([D-Pen2,D-Pen5]enkephalin) opioid agonists on water intake 14 hr deprived rats was studied. All caused a dose related decrease in time spent drinking, with rank order potency dynorphin-(1–13) > morphine ethylketocyclazocine >[D-Pen2,D-Pen5]enkephalin = U50,488H. With the exception morphine, all compounds increased latency to begin but only at highest doses tested. for this endpoint [D-Pen2,D-Pen5]enkephalin U503, 488H. potent inhibition drinking following centrally-given dynorphin-(1–13), that did not affect supports role endogenous dynorphin homeostatic control balance. This function may be primarily mediated through activation receptor since 80–230 times more than selective agonist, U50,488H or ethylketocyclazocine.

参考文章(41)
J.David Leander, Martin D. Hynes, Opioid antagonists and drinking: Evidence of κ-receptor involvement European Journal of Pharmacology. ,vol. 87, pp. 481- 484 ,(1983) , 10.1016/0014-2999(83)90089-4
F. Cantalamessa, G. de Caro, M. Massi, L.G. Micossi, Stimulation of drinking behaviour and of renin release induced by intracerebroventricular injections of D-Ala2,D-Leu5-enkephalin to rats. Pharmacological Research Communications. ,vol. 14, pp. 141- 152 ,(1982) , 10.1016/S0031-6989(82)80095-7
Tetsuo Oka, Kazuko Negishi, Mitsuaki Suda, Aiko Sawa, Masahiko Fujino, Mitsuhiro Wakimasu, Evidence that dynorphin-(1–13) acts as an agonist on opioid κ-receptors European Journal of Pharmacology. ,vol. 77, pp. 137- 141 ,(1982) , 10.1016/0014-2999(82)90008-5
R.P. Maickel, Monique C. Braude, J.E. Zabik, The effects of various narcotic agonists and antagonists on deprivation-induced fluid consumption Neuropharmacology. ,vol. 16, pp. 863- 866 ,(1977) , 10.1016/0028-3908(77)90149-6
S. Watson, H Khachaturian, H Akil, D. Coy, A Goldstein, Comparison of the distribution of dynorphin systems and enkephalin systems in brain Science. ,vol. 218, pp. 1134- 1136 ,(1982) , 10.1126/SCIENCE.6128790
R Przewlocki, W Lason, A. Konecka, C Gramsch, A Herz, L. Reid, The Opioid Peptide Dynorphin, Circadian Rhythms, and Starvation Science. ,vol. 219, pp. 71- 73 ,(1983) , 10.1126/SCIENCE.6129699
John E Jalowiec, Jaak Panksepp, Andrew J Zolovick, Najma Najam, Barbara H Herman, Opioid modulation of ingestive behavior. Pharmacology, Biochemistry and Behavior. ,vol. 15, pp. 477- 484 ,(1981) , 10.1016/0091-3057(81)90280-X
M.F. Piercey, R.A. Lahti, L.A. Schroeder, F.J. Einspahr, C. Barsuhn, U-50488H, a pure kappa receptor agonist with spinal analgesic loci in the mouse. Life Sciences. ,vol. 31, pp. 1197- 1200 ,(1982) , 10.1016/0024-3205(82)90341-1
Donald A. Czech, Michael J. Blake, Elliot A. Stein, Drinking Behavior is Modulated by CNS Administration of Opioids in the Rat Appetite. ,vol. 5, pp. 15- 24 ,(1984) , 10.1016/S0195-6663(84)80045-8